Robert A. Schoevers, MD, PhD

  • 8Articles
  • 56.3KReads
  • 2015–2022Active
  • 35Collaborators
  • 248Citations

About

Robert A. Schoevers, MD, PhD, is affiliated with the University of Groningen, University Medical Center Groningen, Department of Psychiatry, and the Research School of Behavioural and Cognitive Neurosciences in the Netherlands. Since 2015, Schoevers has published extensively on topics including major depressive disorder, anxiety, psychotic disorders, suicide, and patient care in psychiatry. His research includes studies on ketamine treatment for depression, clinical staging of major depressive disorder, and predictive validity of diagnostic criteria for anxiety and depression outcomes. Schoevers has collaborated frequently with Brenda W. J. H. Penninx, Aartjan T. F. Beekman, and other colleagues.

Publications

JCP
Combined Ketamine and Monoamine Oxidase Inhibitors
JCP
JCP
JCP
JCP
JCP
JCP
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.